ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0001726 | abnormal allantois morphology |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0004924 | abnormal behavior |
Gtf2ird1tm2Hrd |
Gtf2ird1tm2Hrd/Gtf2ird1tm2Hrd | B6.129-Gtf2ird1 | color key |
MP:0000913 | abnormal brain development |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001454 | abnormal cued conditioning behavior |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0003743 | abnormal facial morphology |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0002263 | abnormal laryngeal muscle morphology |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0003633 | abnormal nervous system physiology |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | B6.129-Gtf2ird1 | color key |
MP:0004811 | abnormal neuron physiology |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0005322 | abnormal serotonin level |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0003229 | abnormal vitelline vasculature morphology |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001529 | abnormal vocalization |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0003873 | branchial arch hypoplasia |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0011098 | complete embryonic lethality during organogenesis |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003863 | decreased aggression towards mice |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0001364 | decreased anxiety-related response |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0001265 | decreased body size |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0005534 | decreased body temperature |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001262 | decreased body weight |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001698 | decreased embryo size |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003460 | decreased fear-related response |
Gtf2ird1tm1Lro |
Gtf2ird1tm1Lro/Gtf2ird1tm1Lro | involves: 129S1/Sv * 129X1/SvJ * CD-1 | color key |
MP:0010025 | decreased total body fat amount |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0004557 | dilated allantois |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0000292 | distended pericardium |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003984 | embryonic growth retardation |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001222 | epidermal hyperplasia |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0000914 | exencephaly |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0004251 | failure of heart looping |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001399 | hyperactivity |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001402 | hypoactivity |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001405 | impaired coordination |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | B6.129-Gtf2ird1 | color key |
MP:0001405 | impaired coordination |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001745 | increased circulating corticosterone level |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001634 | internal hemorrhage |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0000108 | midline facial cleft |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001722 | pale yolk sac |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0003717 | pallor |
Gtf2ird1Gt(XE465)Byg |
Gtf2ird1Gt(XE465)Byg/Gtf2ird1Gt(XE465)Byg | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0001282 | short vibrissae |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001283 | sparse vibrissae |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |
MP:0001219 | thick epidermis |
Gtf2ird1tm1Hrd |
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | color key |